CA1282809C - Dispositif de desaccouplement eclair - Google Patents
Dispositif de desaccouplement eclairInfo
- Publication number
- CA1282809C CA1282809C CA000563456A CA563456A CA1282809C CA 1282809 C CA1282809 C CA 1282809C CA 000563456 A CA000563456 A CA 000563456A CA 563456 A CA563456 A CA 563456A CA 1282809 C CA1282809 C CA 1282809C
- Authority
- CA
- Canada
- Prior art keywords
- cartridge
- gas
- valve
- flow
- outlet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000007789 sealing Methods 0.000 claims description 3
- 239000007789 gas Substances 0.000 description 688
- 229940090045 cartridge Drugs 0.000 description 516
- 230000003434 inspiratory effect Effects 0.000 description 170
- 239000006199 nebulizer Substances 0.000 description 123
- 210000000188 diaphragm Anatomy 0.000 description 111
- 230000003534 oscillatory effect Effects 0.000 description 99
- 230000029058 respiratory gaseous exchange Effects 0.000 description 95
- 238000002955 isolation Methods 0.000 description 71
- 230000010355 oscillation Effects 0.000 description 65
- 238000009792 diffusion process Methods 0.000 description 56
- 210000004072 lung Anatomy 0.000 description 51
- 238000009423 ventilation Methods 0.000 description 48
- 239000003570 air Substances 0.000 description 40
- 229910001868 water Inorganic materials 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 230000001105 regulatory effect Effects 0.000 description 33
- 239000001301 oxygen Substances 0.000 description 32
- 229910052760 oxygen Inorganic materials 0.000 description 32
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 31
- 230000000541 pulsatile effect Effects 0.000 description 28
- 230000001351 cycling effect Effects 0.000 description 24
- 239000007788 liquid Substances 0.000 description 21
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
- 238000004891 communication Methods 0.000 description 20
- 230000006854 communication Effects 0.000 description 20
- 230000001965 increasing effect Effects 0.000 description 17
- 230000006837 decompression Effects 0.000 description 16
- 238000011068 loading method Methods 0.000 description 16
- 230000032258 transport Effects 0.000 description 16
- 230000008878 coupling Effects 0.000 description 15
- 238000010168 coupling process Methods 0.000 description 15
- 238000005859 coupling reaction Methods 0.000 description 15
- 229940079593 drug Drugs 0.000 description 15
- 239000003814 drug Substances 0.000 description 15
- 239000000443 aerosol Substances 0.000 description 14
- 230000000712 assembly Effects 0.000 description 14
- 238000000429 assembly Methods 0.000 description 14
- 230000003519 ventilatory effect Effects 0.000 description 13
- 238000002663 nebulization Methods 0.000 description 12
- 239000012080 ambient air Substances 0.000 description 11
- 238000010586 diagram Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000004033 plastic Substances 0.000 description 10
- 229920003023 plastic Polymers 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 230000000994 depressogenic effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 241000239290 Araneae Species 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 8
- 230000009975 flexible effect Effects 0.000 description 8
- 230000002685 pulmonary effect Effects 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 239000001569 carbon dioxide Substances 0.000 description 7
- 239000002360 explosive Substances 0.000 description 7
- 238000012544 monitoring process Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 208000036366 Sensation of pressure Diseases 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 125000004122 cyclic group Chemical group 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 230000002459 sustained effect Effects 0.000 description 5
- 210000001364 upper extremity Anatomy 0.000 description 5
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical class OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 229940000425 combination drug Drugs 0.000 description 3
- 230000000881 depressing effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 238000013022 venting Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 208000011623 Obstructive Lung disease Diseases 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 229920002457 flexible plastic Polymers 0.000 description 2
- 230000000870 hyperventilation Effects 0.000 description 2
- 208000000122 hyperventilation Diseases 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 244000144985 peep Species 0.000 description 2
- 230000001630 postinspiratory effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000004202 respiratory function Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 229920000260 silastic Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- 101150034533 ATIC gene Proteins 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010061688 Barotrauma Diseases 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 229920004142 LEXAN™ Polymers 0.000 description 1
- 239000004418 Lexan Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920006074 Nylatron® Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 244000089486 Phragmites australis subsp australis Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 238000012387 aerosolization Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Respiratory Apparatuses And Protective Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US516,133 | 1983-07-21 | ||
| US06/516,133 US4592349A (en) | 1981-08-10 | 1983-07-21 | Ventilator having an oscillatory inspiratory phase and method |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000446110A Division CA1238548A (fr) | 1983-07-21 | 1984-01-26 | Respirateur a phase inspiratoire oscillatoire et methode |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000598775A Division CA1292658C (fr) | 1983-07-21 | 1989-05-04 | Ventilateur a phase inspiratoire oscillante et methode connexe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1282809C true CA1282809C (fr) | 1991-04-09 |
Family
ID=24054267
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000446110A Expired CA1238548A (fr) | 1983-07-21 | 1984-01-26 | Respirateur a phase inspiratoire oscillatoire et methode |
| CA000563456A Expired - Lifetime CA1282809C (fr) | 1983-07-21 | 1988-04-06 | Dispositif de desaccouplement eclair |
| CA000598775A Expired - Lifetime CA1292658C (fr) | 1983-07-21 | 1989-05-04 | Ventilateur a phase inspiratoire oscillante et methode connexe |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000446110A Expired CA1238548A (fr) | 1983-07-21 | 1984-01-26 | Respirateur a phase inspiratoire oscillatoire et methode |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000598775A Expired - Lifetime CA1292658C (fr) | 1983-07-21 | 1989-05-04 | Ventilateur a phase inspiratoire oscillante et methode connexe |
Country Status (1)
| Country | Link |
|---|---|
| CA (3) | CA1238548A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108652632B (zh) * | 2017-03-31 | 2023-07-14 | 中国人民解放军总医院 | 强迫振荡肺功能测试装置及方法 |
| CN116832284A (zh) * | 2023-07-17 | 2023-10-03 | 广州医科大学附属第一医院(广州呼吸中心) | 肺廓清装置 |
| CN118649328B (zh) * | 2024-08-20 | 2024-11-05 | 江苏苏云医疗器材有限公司 | 一种输氧引导分流组件 |
-
1984
- 1984-01-26 CA CA000446110A patent/CA1238548A/fr not_active Expired
-
1988
- 1988-04-06 CA CA000563456A patent/CA1282809C/fr not_active Expired - Lifetime
-
1989
- 1989-05-04 CA CA000598775A patent/CA1292658C/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1238548A (fr) | 1988-06-28 |
| CA1292658C (fr) | 1991-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4592349A (en) | Ventilator having an oscillatory inspiratory phase and method | |
| US5116088A (en) | Ventilator having an oscillatory inspiratory phase and method | |
| US5862802A (en) | Ventilator having an oscillatory inspiratory phase and method | |
| US5007420A (en) | Ventilator having an oscillatory inspiratory phase and method | |
| US4121579A (en) | Ventilator and method | |
| US4198969A (en) | Suction-operated nebulizer | |
| EP1357880B1 (fr) | Appareil permettant la ventilation par percussion intermittente et ensemble a tete respiratoire individuelle utilisable dans ce dernier | |
| US3933171A (en) | Anesthesia breathing circuit with positive end expiratory pressure valve | |
| US4039139A (en) | Ventilator and method | |
| US6067984A (en) | Pulmonary modulator apparatus | |
| EP1414527B1 (fr) | Appareil d'interface pour respirateur de type volumetrique mecanique continu et ventilateur a percussion intra-pulmonaire, combinaison de ceux-ci | |
| US4060078A (en) | Ventilator and method | |
| AU712312B2 (en) | Breathing circuit apparatus for a nebulizer | |
| EP0923397B1 (fr) | Dispositif d'administration dosee de gaz special pour appareil d'oxygenotherapie | |
| US5322057A (en) | Intermittent signal actuated nebulizer synchronized to operate in the exhalation phase, and its method of use | |
| US4210155A (en) | Inspirational inhalation spirometer apparatus | |
| US4176663A (en) | Medical ventilation apparatus | |
| US6516800B1 (en) | Neonatal patient ventilator circuit | |
| US5492115A (en) | Resuscitation breathing apparatus | |
| US5287849A (en) | Medicinal aerosol delivery system and method of use | |
| US4805613A (en) | Ventilator which can be readily transported for emergency situations | |
| US3530856A (en) | Mechanical volume limiting ventilator | |
| US6929006B2 (en) | Device and process for metering breathing gas | |
| EP0519742A1 (fr) | Système de contrôle pour nébuliseur médical | |
| CA1282809C (fr) | Dispositif de desaccouplement eclair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |